Phase 2 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Both the child and their parent or guardian must be willing to understand and agree to participate in the study.
- Children and teenagers between the ages of 8 and 17 (male or female) may be considered.
- A clinician must have confirmed a diagnosis of separation anxiety disorder, generalized anxiety disorder, or social anxiety disorder, using a specific structured interview tool.
- The child must be willing to attend 12 weekly in-person therapy sessions based on Cognitive Behavioural Therapy (CBT).
- The child must already be enrolled in a related study called Protocol 01-M-0192.
- The child must be able to speak, read, and write in English.
- The child must have an IQ above 70, as measured by a standard assessment that will have taken place under Protocol 01-M-0192.
Who may not be able to join:
- Children who are currently taking any psychiatric or psychological medications.
- Children who are currently taking part in another treatment or intervention research study.
- Children who are currently receiving mental health treatment from a provider outside of NIH (the National Institutes of Health).
- Children who have a mental health diagnosis other than an anxiety disorder, as determined by the structured clinical interview used in this study.
- Children who have any serious medical conditions.
- Children who have circumstances that would prevent them from attending in-person therapy sessions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel S Pine, M.D., National Institute of Mental Health (NIMH)
Phone: (301) 594-1318
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pediatric Anxiety Rating Scale (PARS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.